LOS ANGELES, Feb. 7, 2018 /PRNewswire/ -- Groundbreaking
research into the early diagnosis of lung cancer and potential new
treatments have been awarded funding through two lung cancer
research-focused foundations. Lung Cancer Foundation of America
(LCFA) and the International Association for the Study of Lung
Cancer (IASLC) have partnered to fund the Lori Monroe Scholarship
for Lung Cancer Research. These $200,000 grants support promising new research
led by two female scientists, the second year in a row that both
Lori Monroe Scholarship recipients go to women.
Alice Berger, Ph.D. is an
Assistant Member of the Fred Hutchinson Cancer Research Center and
Assistant Professor of Genome Sciences at the University of Washington in Seattle. Her work
focuses on female lung cancer patients who have never smoked, and
have been diagnosed with non-small cell lung cancer (NSCLC).
Christine Lovly, M.D., Ph.D. is
an Assistant Professor of Medicine with the Division of
Hematology-Oncology at the Vanderbilt Ingram Cancer Center and
Vanderbilt University School of
Medicine in Nashville. Her work
focuses on early detection of small cell lung cancer (SCLC), and
the need to develop novel diagnostic and treatment strategies for
patients with this disease, including liquid biopsies.
"The IASLC is proud to join LCFA in providing these grants to
two very promising young investigators. These important research
projects will hopefully lead to encouraging results benefiting many
lung cancer patients," said Dr. Fred R.
Hirsch, M.D., Ph.D., CEO of the IASLC.
"The LCFA/IASLC Lori Monroe Scholarship for Lung Cancer Research
is the kind of private donor funding that is the lifeline for
pioneering researchers like Berger and Lovly to conduct their
important work to help give lung cancer patients improved treatment
options," said Kim Norris, LCFA
President and Co-Founder.
To date, LCFA and the IASLC have partnered to fund more than
$1.8 million in research grants.
About IASLC
The International Association for the Study of Lung Cancer
(IASLC) is the only global organization dedicated to the study of
lung cancer and other thoracic malignancies. Founded in 1974, the
association's membership includes more than 6,500 lung cancer
specialists across all disciplines in over 100 countries, forming a
global network working together to conquer lung and thoracic
cancers worldwide. The association also publishes the Journal of
Thoracic Oncology, the primary educational and informational
publication for topics relevant to the prevention, detection,
diagnosis and treatment of all thoracic malignancies. Visit
www.iaslc.org for more information.
About LCFA
LCFA's mission is the dramatic improvement in survivorship of
lung cancer patients through the funding of transformative science,
with the ultimate goal of curing the disease. Visit lcfamerica.org
for the latest information and to donate.
Press Contacts
Diane Mulligan |
dmullligan@mandccommunications.com | 720.273.0927
Becky Bunn | Becky.bunn@iaslc.org
|720.325.2946
Related Images
alice-berger-ph-d.jpg
Alice Berger, Ph.D.
Assistant Member of the Fred Hutchinson Cancer Research Center and
Assistant Professor of Genome Sciences at the University of Washington in Seattle
christine-lovly-md-ph-d.jpg
Christine Lovly, MD,
Ph.D.
Assistant Professor of Medicine with the Division of
Hematology-Oncology at the Vanderbilt Ingram Cancer Center and
Vanderbilt University School of
Medicine in Nashville
iaslc-lcfa-logos.jpg
IASLC LCFA Logos
Related Links
IASLC
LCFA
View original content with
multimedia:http://www.prnewswire.com/news-releases/two-women-scientists-granted-400k-for-promising-lung-cancer-research-300594725.html
SOURCE Lung Cancer Foundation of America